The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Potential medicinal plants for CNS disorders: an overview
Abstract
Although very few drugs are currently approved by regulatory authorities for treating multi-factorial ailments and disorders of cognition such as Alzheimer's disease, certain plant-derived agents, including, for example, galantamine and rivastigmine (a semi-synthetic derivative of physostigmine) are finding an application in modern medicine. However, in Ayurveda, the Indian traditional system of medicine which is more than 5000 years old, selected plants have long been classified as 'medhya rasayanas', from the Sanskrit words 'medhya', meaning intellect or cognition, and 'rasayana', meaning 'rejuvenation'. These plants are used both in herbal and conventional medicine and offer benefits that pharmaceutical drugs lack. In the present article, an attempt has been made to review the most important medicinal plants, including Ginkgo biloba, St John's wort, Kava-kava, Valerian, Bacopa monniera and Convolvulus pluricaulis, which are widely used for their reputed effectiveness in CNS disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interactions Between Herbal Medicines and Prescribed Drugs: An Updated Systematic Review
Izzo, A. A., & Ernst, E. (2009) · Drugs · doi:10.2165/11317010-000000000-00000 · Cited by 801
Bacopa monniera, a reputed nootropic plant: An overview
Russo, A., & Borrelli, F. (2005) · Phytomedicine · doi:10.1016/j.phymed.2003.12.008 · Cited by 447
C., S., P., N., J., L., J., C., C., H., L., D., & T., R. (2001) · Psychopharmacology · doi:10.1007/s002130100815 · Cited by 342
Chronic Effects of Brahmi (Bacopa monnieri) on Human Memory
Roodenrys, S. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00419-5 · Cited by 313 · cited 1×
“Various clinical studies have also been carried out to establish the efficacy of BM in memory and attention disorders (Maher et al., 2002; Roodenrys et al., 2002; Stough et al., 2001; Dave et al., 1993; Sharma et al., 1987; Singh and Singh, 1980; Ghosh and Kar, 1966; Mukherjee and Dey, 1966).”
BackgroundA comparative study in rodents of standardized extracts of Bacopa monniera and Ginkgo biloba
Das, A., Shanker, G., Nath, C., Pal, R., Singh, S., & Singh, H. K. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00940-1 · Cited by 264
Effect of bacosides A and B on avoidance responses in rats
Singh, H. K., Rastogi, R. P., Srimal, R. C., & Dhawan, B. N. (1988) · Phytotherapy Research · doi:10.1002/ptr.2650020205 · Cited by 163
Effect of Bacopa monniera Linn. (Brāhmi) extract on avoidance responses in rat
Singh, H. K., & Dhawan, B. N. (1982) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(82)90044-7 · Cited by 162
Diaper, A., & Hindmarch, I. (2004) · Phytotherapy Research · doi:10.1002/ptr.1574 · Cited by 89
Nathan, P. J., Tanner, S., Lloyd, J., Harrison, B., Curran, L., Oliver, C., & Stough, C. (2004) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.544 · Cited by 47
Dave, U. P., Chauvan, V., & Dalvi, J. (1993) · The Indian Journal of Pediatrics · doi:10.1007/bf02751207 · Cited by 36
Cited by
Dahham, S., Tabana, Y., Iqbal, M., Ahamed, M., Ezzat, M., Majid, A., & Majid, A. (2015) · Molecules · doi:10.3390/molecules200711808 · Cited by 834
Sarris, J., Panossian, A., Schweitzer, I., Stough, C., & Scholey, A. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.04.002 · Cited by 469
Calabrese, C., Gregory, W. L., Leo, M., Kraemer, D., Bone, K., & Oken, B. (2008) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2008.0018 · Cited by 301
Neuroprotective Natural Products for Alzheimer’s Disease
Chen, X., Drew, J., Berney, W., & Lei, W. (2021) · Cells · doi:10.3390/cells10061309 · Cited by 236
Ayurvedic medicinal plants for Alzheimer’s disease: A review
Rao, R. V., Descamps, O., John, V., & Bredesen, D. E. (2012) · Alzheimer's Research & Therapy · doi:10.1186/alzrt125 · Cited by 213
Metadata
- Authors
- Kumar, V.
- Venue
- Phytotherapy Research
- Publisher
- Wiley
- Published
- 2006
- Volume
- 20
- Issue
- 12
- Pages
- 1023-1035
- ISSN
- 0951-418X (ISSN-L)
- 1099-1573
- OpenAlex
- W2107843728
- Cited by
- 268
- References
- 10
- FWCI
- 20.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
